As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing what could become the first disease-modifying ...
Please provide your email address to receive an email when new articles are posted on . Patients with intermediate junctional epidermolysis bullosa are at risk for kidney-urinary tract manifestations, ...
Dr Joe Wiley, CEO of Amryt Pharma, commented: “Today’s announcement of the positive data from EASE marks another significant milestone for Amryt as we seek approval for FILSUVEZ®. These results also ...
Please provide your email address to receive an email when new articles are posted on . Patients with epidermolysis bullosa are at risk for delayed puberty, which can have a significant impact on bone ...
A family is fighting the detention of a Libyan who came to Minnesota for treatment of a rare skin disease, saying being in ...
A gel derived from birch bark is the first topical medication ever tested in the treatment of epidermolysis bullosa (EB) to heal wounds faster than placebo. The results come from the largest ...
The Food and Drug Administration (FDA) has approved a transformational treatment for one of the most tragic of pediatric skin diseases. The first-of-its kind topical gene therapy for Epidermolysis ...
Tayma struggles with the most severe version of Epidermolysis Bullosa, also known as butterfly disease, a rare disorder that causes skin to blister and crack Zineb Laalej Zineb Laalej tells PEOPLE ...
NEW YORK, NEW YORK - FEBRUARY 03: Eddie Vedder And The Earthlings perform at theBeacon Theatre on February 03, 2022 in New York City. (Photo by Theo Wargo/Getty Images) Pearl Jam’s frontman turns his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback